Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $9.82
- Average 1Y price target
- $11.71+19.25%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF1
- Return on equity2
- Return on assets2
- Debt / equity4
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 2 | $12.50 |
| Last quarter | 6 | $12.42 |
| Last year | 25 | $14.23 |
| All time | 38 | $16.73 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Oct 30, 2026 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Oct 30, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Oct 30, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Oct 27, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Oct 19, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 12, 2026 | TD Cowen | maintain | Buy | Buy |
| Aug 27, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Aug 3, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Aug 3, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Jul 31, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 17, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Jul 13, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Jul 9, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Jul 9, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| May 18, 2026 | TD Cowen | maintain | Buy | Buy |
| May 1, 2026 | UBS | maintain | Neutral | Neutral |
| May 1, 2026 | JP Morgan | maintain | Neutral | Neutral |
| May 1, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 29, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Apr 22, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Apr 13, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Apr 8, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Apr 7, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Apr 7, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Mar 24, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Mar 23, 2026 | TD Cowen | maintain | Buy | Buy |
| Mar 17, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Mar 4, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Mar 2, 2026 | Barclays | downgrade | Overweight | Equal Weight |
| Feb 24, 2026 | Deutsche Bank | downgrade | Buy | Hold |
| Feb 20, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 19, 2026 | Raymond James | maintain | Strong Buy | Strong Buy |
| Feb 9, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Feb 6, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 6, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Feb 6, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 22, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jan 14, 2026 | TD Cowen | maintain | Buy | Buy |
| Jan 13, 2026 | UBS | maintain | Neutral | Neutral |